Tissue Hyperplasia: Influence of a Paclitaxel-eluting Covered Stent—Preliminary Study in a Canine Urethral Model

Abstract

Local delivery of paclitaxel via covered stents has the potential to reduce tissue hyperplasia secondary to stent placement in a canine urethral model. With stent placement, there are distinct differences of tissue hyperplasia between the proximal and distal urethra.